Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
- PMID: 15026261
- DOI: 10.1016/j.expneurol.2003.12.006
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
Abstract
Minocycline is currently under development as a neuroprotective agent in many different brain diseases. In more than a dozen experimental investigations in various models of brain injury, high doses of minocycline have been administered intraperitoneally. This report details new concerns with this route of administration and makes a case for intravenous dosing in experimental animals, particularly for acute neuroprotection, to optimize delivery to the brain and facilitate translation to human studies.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
